尚荣医疗 (002551.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(尚荣医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 318,822,286.53290,575,178.87309,400,196.89335,692,889.50312,396,902.05143,563,339.46484,056,837.33
 营业收入(元) 318,822,286.53290,575,178.87309,400,196.89335,692,889.50312,396,902.05143,563,339.46484,056,837.33
二、营业总成本(元) 320,493,688.72292,172,628.63305,917,592.32314,587,936.92322,079,064.25181,313,893.28482,201,488.74
 营业成本(元) 262,558,829.13233,132,604.08249,556,083.80291,653,859.70241,737,451.94105,219,193.34415,222,231.51
 研发费用(元) 11,542,377.7616,659,363.842,172,817.2314,308,850.5612,938,323.6013,545,578.247,389,618.53
 营业税金及附加(元) 5,209,760.384,901,166.924,548,301.825,566,015.474,127,745.734,802,068.983,999,440.84
 销售费用(元) 4,940,187.471,009,312.198,414,632.60-25,138,923.1717,179,493.1316,206,994.5016,435,623.43
 管理费用(元) 38,493,800.5936,816,615.0443,742,236.0431,628,920.0537,718,183.1737,831,233.9037,825,292.85
 财务费用(元) -2,251,266.61-346,433.44-2,516,479.17-3,430,785.698,377,866.683,708,824.321,329,281.58
  其中:利息费用(元) 849,591.49727,843.69262,064.462,751,056.45-1,431,580.34260,945.44
  其中:利息收入(元) 2,154,334.601,518,110.091,202,894.934,724,876.31-1,839,918.76373,836.09
 资产减值损失(元) ----190,390,086.462,527,206.88--
 信用减值损失(元) 4,122,430.67-4,625,387.643,049,042.58-180,831,230.592,714,969.34-26,232,932.0611,637,944.53
三、其他经营收益
 加:公允价值变动收益(元) -912,195.26515,799.60349,496.80-2,050,061.842,469,596.58875,805.611,298,710.53
 加:投资收益(元) 6,336,152.67-3,977,912.57-59,807.5112,177,495.04-1,102,300.68-905,984.02538,132.62
  其中:对联营企业和合营企业的投资收益(元) --499,113.08-59,807.511,456,992.45144,987.66-907,352.65432,100.15
 其他收益(元) 1,865,505.823,140,574.34959,412.81-798,506.742,117,475.704,231,309.632,391,447.09
四、营业利润(元) 9,740,491.71-6,544,376.037,780,749.25-340,787,438.01-955,214.38-62,524,786.9217,721,583.36
 加:营业外收入(元) 312,939.959,938,436.26711,584.761,863,636.68128,821.48-189,380.65675,955.03
 减:营业外支出(元) 2,457,867.30844,208.02218,591.25106,551.70145,699.3615,704.0939,952.99
五、利润总额(元) 7,595,564.362,549,852.218,273,742.76-339,030,353.03-972,092.26-62,729,871.6618,357,585.40
 减:所得税费用(元) 407,204.05-1,426,101.53512,688.16-54,619,096.21768,568.60-7,734,561.435,112,833.53
六、净利润(元) 7,188,360.313,975,953.747,761,054.60-284,411,256.82-1,740,660.86-54,995,310.2313,244,751.87
(一)按经营持续性分类
  持续经营净利润(元) 7,188,360.313,975,953.747,761,054.60-284,411,256.82-1,740,660.86-54,995,310.2313,244,751.87
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 1,962,025.904,521,344.727,031,710.72-263,178,084.63-693,104.94-54,644,387.1210,452,588.72
  少数股东损益(元) 5,226,334.41-545,390.98729,343.88-21,233,172.19-1,047,555.92-350,923.112,792,163.15
 扣除非经常性损益后的净利润(元) 1,880,882.99554,594.896,102,803.43-270,082,735.40-4,508,353.60-57,635,826.167,278,414.48
七、每股收益
 一、基本每股收益(元) 0.01-0.01-0.31--0.060.01
 二、稀释每股收益(元) 0.01-0.01-0.30--0.060.01
八、其他综合收益(元) 5,960,165.943,928,045.97-11,033,374.73-108,398,304.501,781,971.07994,468.78936,981.59
 归属于母公司股东的其他综合收益(元) 12,912.86-19,363,123.0112,319,483.13-113,855,016.023,012,809.502,028,915.651,061,486.77
 归属于少数股东的其他综合收益(元) 5,947,253.0823,291,168.97-23,352,857.855,456,711.52-1,230,838.43-1,034,446.87-124,505.18
九、综合收益总额(元) 13,148,526.257,953,999.71-3,322,320.13-392,809,561.3241,310.21-54,000,841.4514,181,733.46
 归属于母公司所有者的综合收益总额(元) 1,974,938.76-14,841,778.2919,351,193.85-377,033,100.652,319,704.56-52,615,471.4711,514,075.49
 归属于少数股东的综合收益总额(元) 11,173,587.4922,745,777.99-22,623,513.97-15,776,460.67-2,278,394.35-1,385,369.982,667,657.97
公告日期 2023-10-312023-08-292023-04-292023-04-292022-10-292022-08-302022-04-30
审计意见(境内) 保留意见

前瞻产业研究院